Inadequate Plant Characterization Plagues Trials, AERs – UCLA’s Hardy
This article was originally published in The Tan Sheet
Executive Summary
Preliminary data suggests the characterization of plants cited in adverse event reports published in medical literature is "woefully inadequate," according to Mary Hardy, MD, University of California - Los Angeles, Center for Dietary Research in Botanicals
You may also be interested in...
Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say